Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: January 2022

Nemaura Medical Inc. (NASDAQ: NMRD) Appoints Technical Healthcare Specialist Dr. Arash Ghadar as COO

Posted on January 28, 2022 by MissionIR

NMRD appoints UK-based Dr. Arash Ghadar as Chief Operating Officer, brings decades of healthcare and technology experienceDr. Ghadar previously supervised product development lifecycles, feasibility studies, prototyping, validation, quality management, volume manufacturing, certificationNMRD commercializing sugarBEAT(R) non-invasive, flexible, CGM device, recently completed … Continue reading →

Posted in Nemaura Medical Inc. NMRD | Leave a comment

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Launches New YouTube Video Series Helping People Overcome Barriers to Adopt Plant-Based Lifestyles

Posted on January 28, 2022 by MissionIR

PlantX recently launched ‘Medically Speaking,’ a new YouTube series aimed at promoting plant-based education by dispelling myths and misconceptions around plant-based living Host Adam Kruger will engage experienced healthcare professionals with a passion for promoting plant-based living and wellness The … Continue reading →

Posted in PlantX Life Inc. PLTXF | Leave a comment

Flora Growth Corp. (NASDAQ: FLGC) Names Cannabis Pioneer as Colombian Facility Advisor as Company Prepares for International Growth

Posted on January 28, 2022 by MissionIR

Canada-based Flora Growth Corp. operates cannabis cultivation and extraction processes in-house at its Cosechemos lab and growth facility in central ColombiaThe company has been building a portfolio of cannabis and wellness products and obtaining a variety of licenses and GMP … Continue reading →

Posted in Flora Growth Corp. FLGC | Leave a comment

MissionIRNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Marks History Making Milestone with Initial Shipment of CGM Devices

Posted on January 27, 2022 by MissionIR

Nemaura Medical (NASDAQ: NMRD) is currently in the process of commercializing its sugarBEAT(R) non-invasive, flexible and affordable continuous glucose monitoring (“CGM”) device. “As part of its marketing strategy, NMRD recently completed an initial shipment of sugarBEAT devices to MySugarWatch Limited, … Continue reading →

Posted in Nemaura Medical Inc. NMRD | Leave a comment

MissionIRNewsBreaks – Why Hollywall Entertainment Inc. (HWAL) Is ‘One to Watch’

Posted on January 27, 2022 by MissionIR

Hollywall Entertainment (OTC: HWAL), an innovative telecommunications and broadcasting company, has a portfolio of operating subsidiaries spanning various industries, including infrastructure development, 5G and telecommunications, broadcasting, education, media, and entertainment. Led by founder and CEO/President Darnell Sutton, a highly recognized … Continue reading →

Posted in Hollywall Entertainment Inc. HWAL | Leave a comment

MissionIRNewsBreaks – Save Foods Inc. (NASDAQ: SVFD) Sets Sights on Berry Industry on Heels of Promising Trial Results

Posted on January 27, 2022 by MissionIR

Save Foods (NASDAQ: SVFD), an agri-food tech company specializing in eco crop protection, today announced that it is extending the range of applications of its eco crop protection treatment after successfully applying it to fresh berries in a recent trial. … Continue reading →

Posted in Save Foods Inc. SVFD | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Issues Annual Letter from CEO, Stakeholder Update

Posted on January 27, 2022 by MissionIR

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today provided an annual letter from CEO Chris Bunka and a thorough strategic update to all stakeholders. In the update, Bunka described Lexaria’s key area of focus to … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Key Milestone in Commercialization of Ultra Shear Technology(TM)

Posted on January 27, 2022 by MissionIR

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and process development services to the worldwide food and beverage, biotherapeutics and personal wellness industries, among others, today announced the commissioning of … Continue reading →

Posted in Pressure BioSciences Inc. PBIO | Leave a comment

Lexaria Bioscience Corp. (NASDAQ: LEXX) Emphasizes Oral Cannabinoid Delivery Benefits Following SARS-CoV-2 Study

Posted on January 27, 2022 by MissionIR

The study is available for public viewing and is entitled “Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants” (https://ibn.fm/w6zLQ) Dr. Richard van Breeman, who headed the independent study, explained that smoking and vaping cannabinoids are ineffective against preventing … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Scheduled Release of Q3 Financial Results, Conference Call

Posted on January 27, 2022 by MissionIR

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that it will report financial results for its third quarter ended Dec. 31, 2021, on Thursday, Feb. 10, 2022. According to the announcement, … Continue reading →

Posted in Cybin Inc. CYBN | Leave a comment